Biotech Values

[DFRAI]

You seemed to imply the rheostat switch may only have been tested pre-clinically ...i posted 2 press releases showing they are using in clinic for glioma
they deemed that 30 mg veledimex is the appropriate dose to fine tune release of IL12 and achieve a fine tune for dose vs response

The reason for me posting this.....in part to validate "my belief" and elicit a response from you all...as i believe that there are very capable minds. However, it seems that there is limited interest on your part of digging in and looking for info so i promise...no more posts from me.
GLTA